Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person1
Bausch & Lomb Corp
Company
Primary record20
OpenWorld, Inc. filed SCHEDULE 13D/A
0000891839-26-000476.txt : 20261103 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000891839-26-000460 0002148402 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 10/30/2026 false 0001104038 92346X305 Ope
OpenWorld, Inc. filed SCHEDULE 13D/A
0000891839-26-000475.txt : 20261103 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000891839-26-000459 0002149532 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 10/30/2026 false 0001104038 92346X305 Ope
Bausch & Lomb Corp filed 4
SEC form 4 filed by Bausch & Lomb Corp (CIK 1860742) on 2026-11-02.
Bausch & Lomb Corp filed 4
SEC form 4 filed by Bausch & Lomb Corp (CIK 1860742) on 2026-11-02.
Bausch & Lomb Corp filed 4
SEC form 4 filed by Bausch & Lomb Corp (CIK 1860742) on 2026-11-02.
Bausch & Lomb Corp filed 4
SEC form 4 filed by Bausch & Lomb Corp (CIK 1860742) on 2026-11-02.
KENNAMETAL INC filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. At the Annual Meeting of Shareowners of Kennametal Inc. (the "Company") on October 27, 2026, the Company's Shareowners voted on the election of nine director
Bausch & Lomb Corp filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 28, 2026, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2026 and
Bausch Health Companies Inc. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 28, 2026, Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2026
Bausch & Lomb Corp filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 28, 2026, Nathalie Bernier notified Bausch + Lomb Co
Bausch & Lomb Corp filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 12, 2026, Bausch + Lomb Corporation (the Company ) a
OpenWorld, Inc. filed SCHEDULE 13D
0000891839-26-000459.txt : 20261007 SCHEDULE 13D 1 primary_doc.xml X0202 SCHEDULE 13D 0002149532 XXXXXXXX LIVE Common Stock, par value $0.001 per share 09/30/2026 false 0001104038 92346X305 OpenWorld, Inc. 801 INTERNATIO
OpenWorld, Inc. filed SCHEDULE 13D
0000891839-26-000460.txt : 20261007 SCHEDULE 13D 1 primary_doc.xml X0202 SCHEDULE 13D 0002148402 XXXXXXXX LIVE Common Stock, par value $0.001 per share 09/30/2026 false 0001104038 92346X305 OpenWorld, Inc. 801 INTERNATIO
Bausch Health Companies Inc. filed 4
SEC form 4 filed by Bausch Health Companies Inc. (CIK 885590) on 2026-10-02.
OpenWorld, Inc. filed SCHEDULE 13D/A
0000891839-26-000433.txt : 20261002 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000891839-26-000369 0001723447 XXXXXXXX LIVE 2 Common stock, par value $0.001 per share 09/30/2026 false 0001104038 92346X305 Ope
Bausch Health Companies Inc. filed 4
SEC form 4 filed by Bausch Health Companies Inc. (CIK 885590) on 2026-10-02.
Bausch Health Companies Inc. filed 4
SEC form 4 filed by Bausch Health Companies Inc. (CIK 885590) on 2026-10-02.
SCYNEXIS INC filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Chief Financial Officer On September 9, 2026, the
VerifyMe, Inc. filed SCHEDULE 13D/A
0000891839-26-000369.txt : 20260826 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000891839-26-000327 0001723447 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 08/25/2026 false 0001104038 92346X2062 Ve
Bausch Health Companies Inc. filed 4
SEC form 4 filed by Bausch Health Companies Inc. (CIK 885590) on 2026-08-20.